Fauci says there's currently 'no need for a variant-specific booster'

Amid concerns over the Omicron variant of COVID-19, Dr. Anthony Fauci says variant-specific boosters are not needed "at this point."
Fauci, President Biden's chief medical adviser, during a COVID-19 briefing on Wednesday said that data shows the new Omicron variant "undoubtedly" reduces the protection provided by two doses of an mRNA vaccine. But, he said, early clinical studies suggest booster doses "enhance the vaccine protection" against the Omicron variant.
Additionally, Fauci said, "Our booster vaccine regimens work against Omicron. At this point there is no need for a variant-specific booster."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since the Omicron variant first emerged, there had been questions as to whether booster doses specifically developed to fight it would be necessary. Pfizer recently said, though, that early data suggests its vaccine booster provides protection against the Omicron variant. Pfizer CEO Albert Bourla said that "although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it's clear from these preliminary data that protection is improved with a third dose of our vaccine."
Fauci on Wednesday again urged fully vaccinated Americans to get their COVID-19 booster doses when eligible. Earlier this month, when the first case of the Omicron variant of COVID-19 was confirmed in the United States, Fauci said it would be a "mistake" not to get a booster dose and wait for a potential variant-specific booster, as he noted "we may not need" them.
"If you're eligible for boosting," he said at the time, "get boosted right now."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
France's 'reckoning' over largest-ever child sex abuse trial
The Explainer Joël Le Scouarnec case is latest in a series of high-profile scandals to have prompted 'deep soul searching'
By The Week Staff Published
-
Crossword: March 4, 2025
The Week's daily crossword
By The Week Staff Published
-
Sudoku medium: March 4, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published